This Mukul Agrawal portfolio pharma stock surged 12% in subdued market

Quick Summary:

Shares of Strides Pharma Science surged 12 per cent to Rs 736.

The company is also committed to grow its US business and achieve revenues of $400 million in the next three years.

Shares of Strides Pharma Science surged 12 per cent to Rs 736.05 on the BSE in Wednesday’s intra-day trade in an otherwise subdued market.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Mukul Agrawal portfolio Soft gelatine Pharma OneSource CDMO Biologics CDMO Strides Pharma Science SteriScience Specialty pharma Scheme of Arrangement Stelis Complex Injectables Markets Contract Development and Manufacturing

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-01-01 @ 10:44:23 (5 days ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 639 words

Reading Time: 4 minutes read

Sentences: 23 lines

Sentence Length: 28 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 24800056

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 167 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions